Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial

Golshan, Wong, Loibl, Huober, O'Shaughnessy, Rugo, Wolmark, Ansell, Maag, Sullivan, Metzger-Filho, Von Minckwitz, Geyer, Sikov, Untch (2020) Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial Eur J Surg Oncol (IF: -1) 46(2) 223-228

Links

http://www.ncbi.nlm.nih.gov/pubmed/31606288
http://dx.doi.org/10.1016/j.ejso.2019.10.002

Similar articles

Tools